Edition:
United Kingdom

DexCom Inc (DXCM.OQ)

DXCM.OQ on NASDAQ Stock Exchange Global Select Market

131.60USD
5:36pm BST
Change (% chg)

$-1.60 (-1.20%)
Prev Close
$133.20
Open
$132.84
Day's High
$134.65
Day's Low
$131.30
Volume
116,169
Avg. Vol
341,309
52-wk High
$148.50
52-wk Low
$43.77

Chart for

About

Dexcom, Inc. (Dexcom) is a medical device company. The Company is focused on the design, development and commercialization of continuous glucose monitoring (CGM) systems for ambulatory use by people with diabetes and for use by healthcare providers. The Company's products consist of DexCom G4 PLATINUM and DexCom G5 Mobile. The... (more)

Overall

Beta: 0.22
Market Cap(Mil.): $4,132.42
Shares Outstanding(Mil.): 86.56
Dividend: --
Yield (%): --

Financials

  DXCM.OQ Industry Sector
P/E (TTM): -- 32.37 33.73
EPS (TTM): -0.77 -- --
ROI: -13.69 14.01 14.31
ROE: -21.66 16.77 16.04

BRIEF-DexCom Reports Q1 GAAP Loss Per Share Of $0.28

* Q1 REVENUE $184.4 MILLION VERSUS I/B/E/S VIEW $172.3 MILLION

02 May 2018

Competitors

  Price Chg
Roche Holding Ltd. (ROG.S) CHF236.00 -4.55
Roche Holding Ltd. (RO.S) CHF236.20 -4.80
Johnson & Johnson (JNJ.N) $139.20 +2.64
Abbott Laboratories (ABT.N) $69.65 -1.30
Medtronic PLC (MDT.N) $96.91 +0.36

Earnings vs. Estimates